Zoetis (ZTS) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($886K), but sales were much larger ($2.5M) over the same 12 months.
Past insider buys here: 0 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Mixed: buying, heavier selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase Frank A. Damelio, Director bought 6,650 shares at $75.39 ($501K).
- Trade date
- May 13, 2026
- Disclosed to the SEC
- May 13, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All ZTS insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
ZTS insider transactions (Form 4)
Open-market purchases and sales. 81 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 13SEC | Frank A. DamelioDirectorFirst buy | Buy | 6,65021,458 held (+45%) | $75.39 | $501K | +9.1% | — |
| May 13SEC | Paul BisaroDirectorFirst buy | Buy | 2,00027,862 held (+8%) | $75.88 | $152K | +8.4% | 37 |
| May 12SEC | Michael B. McCallisterDirectorFirst buy | Buy | 3,00024,524 held (+14%) | $77.76 | $233K | +5.8% | — |
| Feb 17SEC | Kristin C. PeckCEO | Sell Plan | 10,800101,337 held (−10%) | $127.55 | $1.4M | -35.5% | — |
| Feb 17SEC | Kristin C. PeckCEO | Sell Plan | 9,200112,137 held (−8%) | $126.46 | $1.2M | -35.0% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for ZTS's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with ZTS in the Research Lab
Pre-set to ZTS's latest insider buy of $10K or more (May 13, 2026: Frank A. Damelio, Michael B. McCallister, Paul Bisaro, $886K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
- After ZTS's buys7, 30 and 90 days later, losses included
- Find buys like this"3 insiders bought within 14 days over $250K after a 20% drop in the last 12 months"
- Compare ZTS vs KODInsider buying and selling side by side
- ZTS's board links9 companies share insiders with ZTS
- Play Insider Call5 real buys a day: guess which beat the market
Share price and insider trades
Zoetis insider trading at a glance (Nov 20, 2026): in the past 12 months, 3 insiders bought $886K and 1 sold $2.5M of ZTS stock on the open market, including a cluster buy that began May 11, 2026; P/E 12.1 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
ZTS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $886K | 3 | — | 0 |
| Q1 2026 | — | 0 | $2.5M | 2 |
Valuation, profit and volume
Source: Yahoo Finance, as of Oct 8, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 3 Zoetis insiders reported open-market purchases totaling $886K, while 1 insider reported sales totaling $2.5M. The most recent cluster buy began on May 11, 2026, when 3 insiders bought a combined $886K. Among insiders with enough purchase history to measure, Paul Bisaro (Director) has the highest Insider Score at 37. 2 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ZTS earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 6, 2026 | -1.3% | None | -2.3%S&P +0.5% | +4.3% |
| May 7, 2026 | -5.9% | None | -25.5%S&P +0.5% | -4.1% |
| Feb 12, 2026 | +3.0% | None | -1.6%S&P -1.5% | -8.7% |
| Nov 4, 2025 | +0.6% | None | -16.5%S&P -0.8% | -1.5% |
| Aug 5, 2025 | +2.2% | None | -3.5%S&P +0.3% | +4.7% |
| May 6, 2025 | +6.7% | None | -1.3%S&P -0.4% | +9.1% |
| Feb 13, 2025 | +2.0% | None | -9.4%S&P +1.1% | +2.4% |
| Nov 4, 2024 | -4.5% | None | -3.7%S&P +1.0% | -0.3% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
ZTS short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded ZTS
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Shelley M CapitoSenate | Sold $1,001 - $15,000 | Oct 21, 2026 | Nov 4, 2026 | +4.0% |
| Markwayne MullinSenate | Sold $15,001 - $50,000 | Nov 10, 2025 | Dec 5, 2025 | -30.3% |
What happened after ZTS insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| May 13, 2026 | Paul BisaroDirector | $152K | +7.2%+7.4% vs S&P | +7.0%+7.1% vs S&P | +2.1%-2.0% vs S&P |
| May 13, 2026 | Frank A. DamelioDirector | $501K | +7.2%+7.4% vs S&P | +7.0%+7.1% vs S&P | +2.1%-2.0% vs S&P |
| May 12, 2026 | Michael B. McCallisterDirector | $233K | +2.6%+3.2% vs S&P | +5.8%+5.9% vs S&P | -2.1%-7.1% vs S&P |
Insiders at Zoetis
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Kristin C. PeckCEO | — | $2.5M | Feb 23, 2026 | — | — |
| Frank A. DamelioDirector | $501K | — | Aug 11, 2026 | — | — |
| Michael B. McCallisterDirector | $233K | — | Jun 11, 2026 | — | — |
| Paul BisaroDirector | $152K | — | May 13, 2026 | — | 37 |
| Julie FullerPresident | — | — | Oct 2, 2026 | — | — |
| Mark StetterDirector | — | — | May 26, 2026 | — | — |
| Louise M. ParentDirector | — | — | May 21, 2026 | — | — |
| Kevin EschPresident | — | — | May 1, 2026 | — | — |
| Keith SarbaughPresident | — | — | Apr 1, 2026 | — | — |
| Gregory NordenDirector | — | — | Mar 10, 2026 | — | — |
| Wetteny JosephCFO | — | — | Feb 23, 2026 | — | — |
| Jamie BrannanPresident | — | — | Feb 23, 2026 | — | — |
| Vanessa BroadhurstDirector | — | — | Feb 23, 2026 | — | — |
| Gavin HattersleyDirector | — | — | Feb 23, 2026 | — | — |
| Antoinette Renee LeatherberryDirector | — | — | Feb 23, 2026 | — | — |
| Nicholas AshtonPresident | — | — | Feb 23, 2026 | — | — |
| Roxanne LaganoPresident | — | — | Feb 23, 2026 | — | — |
| Astorga Jeannette FerranPresident | — | — | Feb 23, 2026 | — | — |
| Rimma DriscollPresident | — | — | Feb 23, 2026 | — | — |
| Willie M. ReedDirector | — | — | Feb 23, 2026 | — | — |
Board links: companies that share insiders with ZTS
Directors and executives who filed Form 4s for ZTS and another company in the last 12 months.
- BLKBlackRock Kristin C. Peck CEO here · Director at BLK · latest filing Oct 2, 2026
- DRCTDirect Digital Holdings Antoinette Renee Leatherberry Director here · Director at DRCT · latest filing Jun 29, 2026
- DXCMDexcom Rimma Driscoll President here · Director at DXCM · latest filing Jun 1, 2026
- HPEHewlett Packard Enterprise Frank A. Damelio Director here · Director at HPE · latest filing Aug 11, 2026
- JNJJohnson & Johnson Vanessa Broadhurst Director here · Evp, Global Corp Affairs at JNJ · latest filing Jul 21, 2026
- MKCMcCormick Gavin Hattersley Director here · Director at MKC · latest filing Oct 5, 2026
- MYGNMyriad Genetics Paul Bisaro Director here · Director at MYGN · latest filing May 14, 2026
- RPRXRoyalty Pharma Gregory Norden Director here · Director at RPRX · latest filing May 15, 2026
- VTRSViatris Frank A. Damelio Director here · Director at VTRS · latest filing Aug 11, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
ZTS stock: common questions
Are Zoetis insiders buying ZTS stock?
In the past 12 months, 3 insiders reported open-market purchases of ZTS worth $886K. The latest was Director Frank A Damelio bought $501K of ZTS at $75.39 — first open-market purchase in our records; raises the stake by 45%.
Are Zoetis insiders selling ZTS stock?
1 insider reported sales worth $2.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ZTS's P/E ratio?
ZTS trades at about 12.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is ZTS's 52-week range?
Over the past year ZTS has traded between $68.64 and $129.63. It last closed at $82.25 on Nov 19, 2026.